These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 7913267)

  • 1. Correlation between changes in cellular immunity and rejection in rat small bowel transplantation.
    Wang P; Zhu L; Liu T; He X; Zhu W
    Transplant Proc; 1994 Jun; 26(3):1557. PubMed ID: 7913267
    [No Abstract]   [Full Text] [Related]  

  • 2. Rejection of small bowel transplants in rats.
    Wang P; Zhu L; Liu T; Zhu W; He X
    Transplant Proc; 1994 Jun; 26(3):1542. PubMed ID: 7913266
    [No Abstract]   [Full Text] [Related]  

  • 3. CD8+ host cells infiltrate the intestinal mucosa after allogeneic small bowel transplantation even in the absence of acute rejection.
    Nüssler NC; Cicalese L; Hoffman RA; Rastellini C; Neuhaus P; Simmons RL; Schraut WH
    Transplant Proc; 1996 Oct; 28(5):2456. PubMed ID: 8907898
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of natural killer cells in mediating graft-versus-host disease following small bowel transplantation in a rat model.
    Fändrich F; Exner B; Papachrysanthou A; Jahnke T; Chambers WH; Zavazava N
    Transplant Proc; 1996 Oct; 28(5):2465-6. PubMed ID: 8907904
    [No Abstract]   [Full Text] [Related]  

  • 5. Apoptosis and CD8 and CD54 cell expression in rat small bowel transplantation.
    Navarro-Zorraquino M; Güemes A; Pastor C; Soria J; Sousa R; Salinas JC; Tejero E; Lozano R
    J Surg Res; 2002 Mar; 103(1):37-40. PubMed ID: 11855915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NK activity during graft-vs-host disease and graft rejection in rats following intestinal transplantation.
    Frezza EE; Gerunda GE; Fassina A; DeFranchis R; Biffi R; Gurakar A; Fagiuoli S; Maffei FA; Van Thiel DH
    Transplant Proc; 1994 Jun; 26(3):1626. PubMed ID: 8030063
    [No Abstract]   [Full Text] [Related]  

  • 7. Histoincompatibility-associated differences in the phenotypes of murine cardiac allograft infiltrating T cells.
    Carlquist JF; Shelby J; Hammond EH; Greenwood JH; Anderson JL
    Immunology; 1994 May; 82(1):149-53. PubMed ID: 7913913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-graft and anti-host antibody responses following small bowel transplantation in the rat.
    Bowles MJ; Wood RF; Pockley AG
    Transplant Proc; 1996 Oct; 28(5):2486. PubMed ID: 8907916
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunologic changes in heterotopic and orthotopic small bowel transplantation in rats.
    Nakai T; Kawabe T; Kurooka K; Okuno K
    Transplant Proc; 1999 Sep; 31(6):2661-4. PubMed ID: 10500761
    [No Abstract]   [Full Text] [Related]  

  • 10. Importance of lymphoid tissue for survival of small bowel allografts.
    Pirenne J; Williams JG; Kim S; Fryer J; Benedetti E; Hakim NS; Médot M; Najarian JS; Gruessner RW; Dunn DL
    Transplant Proc; 1995 Feb; 27(1):1359-60. PubMed ID: 7878911
    [No Abstract]   [Full Text] [Related]  

  • 11. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment.
    Drobyski WR; Majewski D; Ozker K; Hanson G
    J Immunol; 1998 Sep; 161(5):2610-9. PubMed ID: 9725263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rejection of rat cardiac xenografts by mouse CD4 or CD8 T cells.
    Sakakibara N; Jamieson SW; Wolf P; Weisberg D; Click RE
    Transplant Proc; 1995 Feb; 27(1):264-5. PubMed ID: 7878996
    [No Abstract]   [Full Text] [Related]  

  • 13. CD4+ T cells are both necessary and sufficient for islet xenograft rejection.
    Gill RG; Wolf L; Daniel D; Coulombe M
    Transplant Proc; 1994 Jun; 26(3):1203. PubMed ID: 7913259
    [No Abstract]   [Full Text] [Related]  

  • 14. [CD4+, CD25+ regulatory T-lymphocytes: current concepts and therapeutic potential].
    Salomon B
    J Soc Biol; 2002; 196(4):263-6. PubMed ID: 12645292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leflunomide immunosuppression in rat small intestinal transplantation.
    Foster PF; Xiao F; Kociss K; Chong AS; Sankary HN; McChesney L; Cohn S; Williams JW
    Transplant Proc; 1994 Jun; 26(3):1599-600. PubMed ID: 8030053
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased number of intraepithelial lymphocytes in rejected small-bowel allografts: an analysis of subpopulations involved.
    Oberhuber G; Schmid T; Thaler W; Luze T; Klima G; Margreiter R
    Transplant Proc; 1990 Dec; 22(6):2454-5. PubMed ID: 2264104
    [No Abstract]   [Full Text] [Related]  

  • 17. Histocompatibility complex subloci differences in small bowel transplantation: their influence on graft rejection.
    Gundlach M; Rogiers X; Broelsch CE
    Transplant Proc; 1996 Oct; 28(5):2447-8. PubMed ID: 8907890
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of CD4 and CD8 knockout mice to study the role of T-cell subsets in allotransplant rejection.
    Krieger NR; Fathman CG
    J Heart Lung Transplant; 1997 Mar; 16(3):263-7. PubMed ID: 9087868
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of donor natural killer cells on lethal graft-versus-host disease following small bowel transplantation in the rat.
    Okamoto M; Arakawa K; Akioka K; Fujiwara I; Takeshita K; Oka T
    Transplant Proc; 1996 Oct; 28(5):2467-8. PubMed ID: 8907905
    [No Abstract]   [Full Text] [Related]  

  • 20. Fulminant graft-versus-host disease after FK 506 treatment in fully allogeneic small bowel transplantation.
    de Bruin RW; HogenEsch H; Heineman E; Jeekel J; Marquet RL
    Transplant Proc; 1991 Dec; 23(6):3257-9. PubMed ID: 1721429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.